BioRaptor offers an advanced AI-powered platform designed to optimize bioprocessing across various sectors, including biopharma and industrial biotechnology. The platform excels in data integration, harmonizing information from multiple sources to create a centralized repository that facilitates data-driven decision-making. By employing machine learning algorithms, BioRaptor enables real-time monitoring of critical parameters such as Glucose Consumption Rate (GCR), Oxygen Transfer Rate (OTR), and Oxygen Uptake Rate (OUR). This capability allows for early detection of anomalies, enhancing the reliability of experiments and reducing the risk of failure. Additionally, BioRaptor's digital twin functionality allows users to run virtual experiments, simulating various scenarios to predict outcomes without the need for extensive wet lab work.

The platform's analytical tools empower scientists to uncover insights quickly through intuitive data visualizations, enabling them to identify correlations and optimize processes effectively. BioRaptor supports the entire experiment cycle, from initial research to product commercialization, by streamlining collaboration among team members and providing a robust framework for process development. This integrated approach not only accelerates the transition from research to market but also improves yields and reduces costs, making BioRaptor a valuable asset for organizations aiming to enhance their bioprocessing capabilities.

Israel

Biology is at a tipping point for implementing AI - thanks to rich data, tool availability, compute capacity, and measurable business impact. Our goal is to empower every scientist and biotech firm, making AI-powered insights a natural part of every workflow.  From alt-protein foods to new biopharmaceuticals, bioraptor will make it easier, quicker and more cost-effective for scientists to discover, develop and scale processes that get much-needed food and pharma products into the hands of those who need them.

BioRaptor

Company Details